Regulations.gov document
USPTO Letters of March 13, 2019 Concerning Patent Term Extension Applications Based on the…
Other · FDA-2019-E-3063 · posted Jun 25, 2019
Key facts
| Document ID | FDA-2019-E-3063-0001 |
|---|---|
| Title | USPTO Letters of March 13, 2019 Concerning Patent Term Extension Applications Based on the NDA Approvals for MEKTOVI and BRAFTOVI |
| Document type | Other |
| Subtype | Letter(s) |
| Agency | FDA |
| Docket | FDA-2019-E-3063 |
| Posted | Jun 25, 2019 |
| Comment period opens | Jun 25, 2019 |
At a glance
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: